|
176
|
| 714 |
Status epilepticus
|
|
increases_expression of
|
SLC12A2
|
in pilocarpine model
|
| 715 |
Status epilepticus
|
|
decreases_expression of
|
SLC12A5
|
in pilocarpine model
|
|
18550034
|
Status epilepticus
|
|
216
|
| 851 |
Pilocarpine
|
|
decreases_expression of
|
VIM
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 852 |
Pilocarpine
|
|
decreases_expression of
|
ACTA1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 854 |
Pilocarpine
|
|
decreases_expression of
|
ENO2
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 855 |
Pilocarpine
|
|
decreases_expression of
|
PDHB
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 857 |
Pilocarpine
|
|
decreases_expression of
|
ACTB
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 858 |
Pilocarpine
|
|
decreases_expression of
|
HSPD1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 874 |
Pilocarpine
|
|
decreases_expression of
|
ALDOA
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 877 |
Pilocarpine
|
|
decreases_expression of
|
PRPS1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 878 |
Pilocarpine
|
|
decreases_expression of
|
SNAP25
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 879 |
Pilocarpine
|
|
decreases_expression of
|
ARHGDIA
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 880 |
Pilocarpine
|
|
decreases_expression of
|
GLO1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 881 |
Pilocarpine
|
|
decreases_expression of
|
STMN1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 882 |
Pilocarpine
|
|
decreases_expression of
|
NME1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 898 |
Pilocarpine
|
|
decreases_expression of
|
ACP1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 899 |
Pilocarpine
|
|
decreases_expression of
|
UBE2N
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 900 |
Pilocarpine
|
|
decreases_expression of
|
HBA2
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 901 |
Pilocarpine
|
|
decreases_expression of
|
AK1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 903 |
Pilocarpine
|
|
decreases_expression of
|
TAGLN3
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 904 |
Pilocarpine
|
|
decreases_expression of
|
CBR1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 905 |
Pilocarpine
|
|
decreases_expression of
|
GSTM5
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 906 |
Pilocarpine
|
|
decreases_expression of
|
HBB
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 917 |
Pilocarpine
|
|
decreases_expression of
|
TUBB2B
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 988 |
Pilocarpine
|
|
increases_expression of
|
NEFM
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 989 |
Pilocarpine
|
|
increases_expression of
|
HSP90AB1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 991 |
Pilocarpine
|
|
increases_expression of
|
NRP2
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 992 |
Pilocarpine
|
|
increases_expression of
|
HSPA1B
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 993 |
Pilocarpine
|
|
increases_expression of
|
SEMA6C
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 995 |
Pilocarpine
|
|
increases_expression of
|
TUBA4A
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 997 |
Pilocarpine
|
|
increases_expression of
|
TUBA1A
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1000 |
Pilocarpine
|
|
increases_expression of
|
PDIA6
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1001 |
Pilocarpine
|
|
increases_expression of
|
HOMER2
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1003 |
Pilocarpine
|
|
increases_expression of
|
DDT
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1004 |
Pilocarpine
|
|
increases_expression of
|
PKM
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1005 |
Pilocarpine
|
|
increases_expression of
|
SYN2
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1006 |
Pilocarpine
|
|
increases_expression of
|
ATP5F1B
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1007 |
Pilocarpine
|
|
increases_expression of
|
VDAC2
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1009 |
Pilocarpine
|
|
increases_expression of
|
SPTAN1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1010 |
Pilocarpine
|
|
increases_expression of
|
NRGN
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1011 |
Pilocarpine
|
|
increases_expression of
|
INA
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1012 |
Pilocarpine
|
|
increases_expression of
|
MSI1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
| 1013 |
Pilocarpine
|
|
increases_expression of
|
COX6B1
|
after 12 h in pilocarpine-induced temporal lobe epilepsy model
|
|
18186018
|
Epilepsy, temporal lobe
|
|
332
|
| 1310 |
Status epilepticus
|
|
increases_activity of
|
PRKACA
|
in pilocarpine model
|
| 1311 |
Status epilepticus
|
|
increases_phosphorylation of
|
GRIA1
|
in pilocarpine model
|
|
19501060
|
Status epilepticus
|
|
333
|
| 1312 |
Status epilepticus
|
|
increases_expression of
|
CACNA1H
|
in pilocarpine model
|
|
19357270
|
Status epilepticus
Epilepsy, temporal lobe
|
|
335
|
| 1316 |
Pilocarpine
|
|
affects_activity of
|
CASP8
|
in pilocarpine rat model
|
| 1317 |
Pilocarpine
|
|
affects_activity of
|
CASP3
|
in pilocarpine rat model
|
| 1318 |
Pilocarpine
|
NOT |
affects_activity of
|
CASP9
|
in pilocarpine rat model
|
|
19879360
|
Status epilepticus
Epilepsy, temporal lobe
|
|
337
|
| 1321 |
Pilocarpine
|
|
increases_activity of
|
glucose catabolic process
|
in pilocarpine rat model
|
|
19875051
|
Status epilepticus
Epilepsy, temporal lobe
|
|
339
|
| 1333 |
Pilocarpine
|
|
increases_activity of
|
response to oxidative stress
|
in pilocarpine rat model
|
| 1334 |
Buspirone hydrochloride
|
|
decreases_activity of
|
response to oxidative stress
|
in pilocarpine rat model
|
| 13705 |
response to oxidative stress
|
|
increases_quantity of
|
NO
|
in pilocarpine rat model
|
| 13706 |
response to oxidative stress
|
|
increases_activity of
|
lipid oxidation
|
in pilocarpine rat model
|
|
19800952
|
Status epilepticus
|
|
406
|
| 1740 |
Pilocarpine
|
|
interacts (colocalizes) with
|
CHRM1
|
in pilocarpine model
|
| 1745 |
CHRM1
|
|
affects_activity of
|
convulsive seizures
|
in pilocarpine model
|
| 1746 |
CHRM1
|
|
increases_activity of
|
PLCG1
|
in pilocarpine model
|
|
12713643
|
Neurological
Status epilepticus
|
|
439
|
| 1915 |
PLCG1
|
|
affects_quantity of
|
Phosphatidylinositol-4,5-bisphosphate
|
in pilocarpine model
|
| 1924 |
Phosphatidylinositol-4,5-bisphosphate
|
|
affects_activity of
|
Diacylglycerol
|
in pilocarpine model
|
| 1925 |
Phosphatidylinositol-4,5-bisphosphate
|
|
affects_activity of
|
Inositol 1,4,5-trisphosphate
|
in pilocarpine model
|
|
1471196
|
Status epilepticus
|
|
440
|
| 1940 |
Inositol 1,4,5-trisphosphate
|
|
interacts (colocalizes) with
|
ITPR1
|
in pilocarpine model
|
|
1648604
|
Neurological
Status epilepticus
|
|
442
|
| 1942 |
ITPR1
|
|
increases_activity of
|
inositol 1,4,5-trisphosphate-sensitive calcium-release
|
in pilocarpine model
|
|
18406528
|
Status epilepticus
|
|
449
|
| 1982 |
Ca2+
|
|
increases_activity of
|
abnormal excitatory postsynaptic currents
|
in pilocarpine model
|
|
11283235
|
Status epilepticus
Epilepsy, temporal lobe
|
|
540
|
| 2730 |
Status epilepticus
|
|
decreases_expression of
|
GRIA2
|
in pilocarpine model
|
|
19222700
|
Status epilepticus
|
|
542
|
| 2738 |
Status epilepticus
|
|
increases_activity of
|
response to amphetamine
|
in pilocarpine model
|
| 2741 |
Status epilepticus
|
|
decreases_quantity of
|
Dopamine
|
in pilocarpine model
|
| 2742 |
Metamfetamine
|
|
increases_quantity of
|
Dopamine
|
in pilocarpine model
|
| 2743 |
Metamfetamine
|
|
increases_quantity of
|
Glutamate
|
in pilocarpine model
|
|
19126440
|
Status epilepticus
|
|
546
|
| 2762 |
Pilocarpine
|
|
decreases_expression of
|
GRM2
|
in pilocarpine model
|
| 5928 |
Pilocarpine
|
|
decreases_expression of
|
GRM3
|
in pilocarpine model
|
|
18585369
|
Status epilepticus
|
|
547
|
| 2763 |
Status epilepticus
|
|
affects_expression of
|
EPOR
|
in pilocarpine model
|
| 13800 |
EPO
|
|
decreases_activity of
|
abnormal blood-brain barrier function
|
in pilocarpine model
|
| 13801 |
EPO
|
|
decreases_activity of
|
neuron death
|
in pilocarpine model
|
| 13802 |
EPO
|
|
decreases_activity of
|
microglial cell activation
|
in pilocarpine model
|
| 13803 |
EPO
|
|
decreases_activity of
|
abnormal hippocampus granule cell morphology
|
in pilocarpine model
|
| 13804 |
EPO
|
|
decreases_activity of
|
convulsive seizures
|
|
|
18479396
|
Status epilepticus
|
|
548
|
| 2764 |
Pilocarpine
|
|
increases_quantity of
|
Glutamate
|
in pilocarpine model
|
| 2765 |
VPU
|
|
decreases_quantity of
|
Glutamate
|
in pilocarpine model
|
| 5923 |
Pilocarpine
|
|
increases_quantity of
|
Aspartate
|
in pilocarpine model
|
| 5924 |
Pilocarpine
|
NOT |
affects_quantity of
|
GABA
|
in pilocarpine model
|
| 5925 |
VPU
|
|
decreases_quantity of
|
Aspartate
|
in pilocarpine model
|
| 5926 |
Valproic acid
|
|
decreases_quantity of
|
Asparagine
|
in pilocarpine model
|
| 5927 |
Valproic acid
|
|
decreases_quantity of
|
Glutamate
|
in pilocarpine model
|
|
18439803
|
Status epilepticus
|
|
562
|
| 2914 |
Status epilepticus
|
|
decreases_expression of
|
GRIA1
|
in lithium/pilocarpine induced model
|
| 2918 |
Status epilepticus
|
|
decreases_expression of
|
GRIA2
|
in lithium/pilocarpine induced model
|
| 2919 |
Status epilepticus
|
|
increases_expression of
|
SLC1A1
|
in pilocarpine model
|
|
14675153
|
Status epilepticus
|
|
565
|
| 2949 |
Pilocarpine
|
|
decreases_activity of
|
ATP1A1
|
in pilocarpine model
|
| 2950 |
Pilocarpine
|
|
decreases_activity of
|
ALAD
|
in pilocarpine model
|
| 2951 |
Lipoate
|
|
increases_activity of
|
ATP1A1
|
in pilocarpine model
|
| 2952 |
Lipoate
|
|
increases_activity of
|
ALAD
|
in pilocarpine model
|
|
20026167
|
Status epilepticus
|
|
571
|
| 2984 |
Lipoate
|
|
increases_activity of
|
CHAT
|
in pilocarpine model
|
| 2989 |
Lipoate
|
|
increases_activity of
|
ACHE
|
in pilocarpine model
|
| 2990 |
Lipoate
|
|
increases_activity of
|
learning or memory
|
in pilocarpine model
|
|
19669875
|
Status epilepticus
|
|
585
|
| 3085 |
convulsive seizures
|
|
decreases_expression of
|
KCNMA1
|
in pilocarpine model
|
| 3086 |
convulsive seizures
|
|
decreases_quantity of
|
KCNMA1
|
in pilocarpine model
|
|
18295190
|
Epilepsy, temporal lobe
|
|
596
|
| 3145 |
Pilocarpine
|
|
decreases_quantity of
|
Noradrenaline
|
in all stages of status epilepticus in pilocarpine model
|
| 3151 |
Pilocarpine
|
|
increases_quantity of
|
Dopamine
|
in all stages of status epilepticus in pilocarpine model
|
| 3152 |
Pilocarpine
|
|
increases_quantity of
|
Serotonin
|
in acute stage of status epilepticus in pilocarpine model
|
| 3154 |
Pilocarpine
|
|
decreases_quantity of
|
Glutamate
|
in acute stage of status epilepticus in pilocarpine model
|
| 3155 |
Pilocarpine
|
|
decreases_quantity of
|
Aspartate
|
in acute stage of status epilepticus in pilocarpine model
|
| 3156 |
Pilocarpine
|
|
increases_quantity of
|
GABA
|
in acute stage of status epilepticus in pilocarpine model
|
| 3163 |
Pilocarpine
|
|
decreases_quantity of
|
Glycine
|
in the silent phase of status epilepticus in pilocarpine model
|
| 3164 |
Pilocarpine
|
|
decreases_quantity of
|
GABA
|
in the silent phase of status epilepticus in pilocarpine model
|
| 3165 |
Pilocarpine
|
|
increases_quantity of
|
Glutamate
|
in the silent phase of status epilepticus in pilocarpine model
|
| 3194 |
Pilocarpine
|
|
increases_quantity of
|
GABA
|
in SRS stage of status epilepticus in pilocarpine model
|
| 3198 |
Pilocarpine
|
|
increases_quantity of
|
Glycine
|
in SRS stage of status epilepticus in pilocarpine model
|
| 3202 |
Pilocarpine
|
|
increases_quantity of
|
Glutamate
|
in SRS stage of status epilepticus in pilocarpine model
|
| 3203 |
Pilocarpine
|
|
increases_quantity of
|
Aspartate
|
in SRS stage of status epilepticus in pilocarpine model
|
|
8112229
|
Status epilepticus
|
|
611
|
| 3226 |
Pilocarpine
|
NOT |
affects_activity of
|
regulation of neurotransmitter secretion
|
in pilocarpine model of epilepsy
|
| 3230 |
Status epilepticus
|
NOT |
affects_activity of
|
regulation of neurotransmitter uptake
|
in pilocarpine model of epilepsy
|
| 3235 |
Status epilepticus
|
|
affects_activity of
|
regulation of neurotransmitter secretion
|
in pilocarpine model of epilepsy
|
|
14746897
|
Status epilepticus
|
|
616
|
| 3273 |
Pilocarpine
|
|
increases_quantity of
|
Ca2+
|
in the pilocarpine model of temporal lobe epilepsy
|
|
11382382
|
Epilepsy, temporal lobe
|
|
617
|
| 3275 |
Status epilepticus
|
|
increases_quantity of
|
ATP2A2
|
in pilocarpine model
|
| 3276 |
Status epilepticus
|
NOT |
affects_activity of
|
calcium ion transmembrane transport
|
in pilocarpine model
|
|
15288437
|
Status epilepticus
|
|
619
|
| 3279 |
Status epilepticus
|
|
increases_expression of
|
ATP2A2
|
in pilocarpine model of epilepsy
|
| 3280 |
Status epilepticus
|
|
increases_expression of
|
ATP2B1
|
in pilocarpine model of epilepsy
|
|
15104385
|
Status epilepticus
Epilepsy, temporal lobe
|
|
620
|
| 3281 |
Status epilepticus
|
|
affects_quantity of
|
APBA1
|
in pilocarpine model of temporal lob epilepsy
|
|
14706732
|
Status epilepticus
Epilepsy, temporal lobe
|
|
624
|
| 3316 |
convulsive seizures
|
|
affects_activity of
|
abnormal GABA-mediated receptor currents
|
in pilocarpine model
|
|
20133704
|
Epilepsy, temporal lobe
|
|
625
|
| 3317 |
Pilocarpine
|
|
decreases_quantity of
|
GABRA1
|
in pilocarpine model of temporal lobe epilepsy
|
| 3318 |
Pilocarpine
|
|
decreases_quantity of
|
GABRA4
|
in pilocarpine model of temporal lobe epilepsy
|
|
20133704
|
Epilepsy, temporal lobe
|
|
630
|
| 3346 |
Status epilepticus
|
|
increases_activity of
|
peptidyl-tyrosine phosphorylation
|
in acute phase of status epilepticus in pilocarpine model
|
|
9766394
|
Status epilepticus
|
CIDeRplus